Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

par Maughan, A., Sadigh, K., Angulo-Diaz, V., Mandimika, C., Villanueva, M., Lim, J. K., Ogbuagu, O.
Publié dans BMC Infect Dis (2019)

Caught in the Act: In Vivo Development of Macrolide Resistance to Campylobacter jejuni Infection

par Lindow, J. C., Poly, F., Tribble, D. R., Guerry, P., Carmolli, M. P., Baqar, S., Porter, C. K., Pierce, K. K., Darsley, M. J., Sadigh, K. S., Dill, E. A., Kirkpatrick, B. D.
Publié 2010